ABT (Abbott) Company Short-Term Debt

Brandmark of Abbott Laboratories (ABT)

Abbott Laboratories (ABT) leverages significant pricing power due to the indispensable nature of its glucose monitoring systems. The short-term borrowing level on the GURU.Markets terminal line chart, where 1.06 serves as the current metric reading, illustrates the dynamics of liabilities. The defensive qualities of the business guarantee stability during crises, while a flawless brand image confirms its status as the gold standard of reliability in medical diagnostics.

ABT Abbott Labs Short-Term Debt Volume (07/04/2022 - 10/29/2026)

Metric breakdowns and analytics for Abbott Corp. (ABT)

- current quotes and average value forecast:
Price Chart Abbott|ABT - Broker Consensus Forecast
- business market valuation indicators:
Market Value Abbott Laboratories|ABT - Total Enterprise Value
- shareholders' equity book value data:
Net Assets per Single Share Abbott|ABT - Book Valuation of Business|Market Cap to Net Assets Ratio abbott.com|ABT - Aggregate Business Assets
- debt and liquidity details:
Total Debt to Capital Abbott Laboratories|ABT - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Capital Abbott Laboratories|ABT - Company Total Debt|Debt to Book Value Abbott Laboratories|ABT - Company Long-Term Loans and Borrowings|Company Short-Term Debt Abbott
Initial company analysis:Abbott - ABT
Manufactured products of Abbott Corp.

The extensive diversification of Abbott Laboratories (ABT) within the medical sector ensures high cash flow stability. Short-term financial debt measures obligations maturing within one year, reflecting current liquidity and the cost of operational management. By analyzing the value of 1.06, an investor distinguishes systemic stability from temporary cash flow gaps. Regular servicing of these loans confirms the business's financial health. Short-term financial debt dynamics allow for an assessment of the efficiency of debt capital rebalancing.

Competing companies

TMO - Company Short-Term Debt|GEHC (GE HealthCare Technologies Inc.) - Company Short-Term Indebtedness|Mettler-Toledo International Inc. (MTD) - Company Short-Term Debt|Short-Term Debt Waters Technologies (WAT)|Company Short-Term Debt Bio-Techne Corporation|bruker.com (BRKR) - Short-Term Debt Volume|Company Current Liabilities AZTA (Azenta)|Amount of Current Liabilities VREX|Company Short-Term Debts SMLR (Semler Scientific Corp)|Short-Term Debt Volume Butterfly Corp (BFLY)|Mesa Laboratories, Inc. - Company Short-Term Debts|quantum-si.com (QSI) - Company Current Liabilities|NNOX (Nano-X) - Company Current Liabilities|Quanterix Corp. - Company Short-Term Loans and Borrowings|Company Short-Term Debt 908 Devices Corp|Company Current Liabilities CapsoVision Medical (CV)|Company Short-Term Debts MXCT|RPID - Short-Term Debt|Company Short-Term Debts SEER (Seer)|HYPR: Company Short-Term Indebtedness|FONAR Corp - Company Short-Term Debts|Short-Term Debt Volume Daxor Corporation DXR|MDAI: Company Short-Term Debts|Company Current Liabilities Organovo|ACON (Aclarion, Inc.) - Company Short-Term Debts|Company Short-Term Debts Akoya|Company Short-Term Debt ThermoGenesis Holdings Inc. (THMO)|Company Short-Term Debt TLIS (talis.bio)|T2 Biosystems, Inc. - Company Current Liabilities